Goldman Sachs updated its top stock picks, removing Interactive Brokers and adding Vertex Pharmaceuticals.
1 report, 1 independent
Updated Sep 2
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Goldman Sachs updated its top stock picks, removing Interactive Brokers and adding Vertex Pharmaceuticals.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Goldman Sachs
American investment bank
-
Interactive Brokers
American multinational brokerage firm
-
Vertex Pharmaceuticals
American pharmaceutical company
Related events
- Vertex Pharmaceuticals trades on Nasdaq, files reports with the SEC, and has an executive named Duncan McKechnie.
- Vertex Pharmaceuticals presented updates at a Wells Fargo conference on September 12, 2026.
- Vertex Pharmaceuticals had required 13F filings with the SEC and its stock traded on the Nasdaq exchange on September 8, 2026.
- Vertex Pharmaceuticals CEO leads the company's strategic business direction.